nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—Xanthopsia—Hydrochlorothiazide—nephrolithiasis	0.0493	0.067	CcSEcCtD
Sildenafil—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0335	0.0454	CcSEcCtD
Sildenafil—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0205	0.0278	CcSEcCtD
Sildenafil—CYP2C19—urine—nephrolithiasis	0.0185	0.0979	CbGeAlD
Sildenafil—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0233	CcSEcCtD
Sildenafil—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0218	CcSEcCtD
Sildenafil—CYP2C9—urine—nephrolithiasis	0.0144	0.0759	CbGeAlD
Sildenafil—CYP2E1—urine—nephrolithiasis	0.0136	0.0719	CbGeAlD
Sildenafil—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0125	0.017	CcSEcCtD
Sildenafil—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0165	CcSEcCtD
Sildenafil—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0156	CcSEcCtD
Sildenafil—CYP3A4—urine—nephrolithiasis	0.011	0.0579	CbGeAlD
Sildenafil—CYP2D6—urine—nephrolithiasis	0.0108	0.0569	CbGeAlD
Sildenafil—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0135	CcSEcCtD
Sildenafil—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00971	0.0132	CcSEcCtD
Sildenafil—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00971	0.0132	CcSEcCtD
Sildenafil—Gout—Hydrochlorothiazide—nephrolithiasis	0.00965	0.0131	CcSEcCtD
Sildenafil—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.0095	0.0501	CbGeAlD
Sildenafil—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0094	0.0128	CcSEcCtD
Sildenafil—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0125	CcSEcCtD
Sildenafil—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00912	0.0124	CcSEcCtD
Sildenafil—ABCC5—nephron tubule—nephrolithiasis	0.00865	0.0457	CbGeAlD
Sildenafil—PDE5A—renal system—nephrolithiasis	0.0086	0.0454	CbGeAlD
Sildenafil—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00823	0.0112	CcSEcCtD
Sildenafil—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00813	0.0429	CbGeAlD
Sildenafil—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00752	0.0102	CcSEcCtD
Sildenafil—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00741	0.0101	CcSEcCtD
Sildenafil—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00738	0.01	CcSEcCtD
Sildenafil—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00718	0.00975	CcSEcCtD
Sildenafil—Injury—Hydrochlorothiazide—nephrolithiasis	0.00712	0.00966	CcSEcCtD
Sildenafil—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00699	0.00949	CcSEcCtD
Sildenafil—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00945	CcSEcCtD
Sildenafil—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00941	CcSEcCtD
Sildenafil—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00941	CcSEcCtD
Sildenafil—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0069	0.00937	CcSEcCtD
Sildenafil—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0069	0.00937	CcSEcCtD
Sildenafil—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00687	0.00933	CcSEcCtD
Sildenafil—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00673	0.00914	CcSEcCtD
Sildenafil—ABCC10—renal system—nephrolithiasis	0.00657	0.0347	CbGeAlD
Sildenafil—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00888	CcSEcCtD
Sildenafil—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00874	CcSEcCtD
Sildenafil—ABCC10—kidney—nephrolithiasis	0.00635	0.0335	CbGeAlD
Sildenafil—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00857	CcSEcCtD
Sildenafil—ABCC10—cortex of kidney—nephrolithiasis	0.00619	0.0327	CbGeAlD
Sildenafil—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00615	0.00835	CcSEcCtD
Sildenafil—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00604	0.0082	CcSEcCtD
Sildenafil—ABCC4—nephron tubule—nephrolithiasis	0.006	0.0317	CbGeAlD
Sildenafil—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00811	CcSEcCtD
Sildenafil—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00811	CcSEcCtD
Sildenafil—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00595	0.00808	CcSEcCtD
Sildenafil—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00802	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00589	0.008	CcSEcCtD
Sildenafil—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00579	0.00786	CcSEcCtD
Sildenafil—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00783	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00783	CcSEcCtD
Sildenafil—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00569	0.00773	CcSEcCtD
Sildenafil—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00767	CcSEcCtD
Sildenafil—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00767	CcSEcCtD
Sildenafil—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00748	CcSEcCtD
Sildenafil—ABCC4—renal system—nephrolithiasis	0.00545	0.0288	CbGeAlD
Sildenafil—ABCC4—kidney—nephrolithiasis	0.00527	0.0278	CbGeAlD
Sildenafil—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00713	CcSEcCtD
Sildenafil—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00709	CcSEcCtD
Sildenafil—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00707	CcSEcCtD
Sildenafil—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00516	0.007	CcSEcCtD
Sildenafil—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00698	CcSEcCtD
Sildenafil—ABCC4—cortex of kidney—nephrolithiasis	0.00513	0.0271	CbGeAlD
Sildenafil—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00692	CcSEcCtD
Sildenafil—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00688	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.005	0.00678	CcSEcCtD
Sildenafil—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00675	CcSEcCtD
Sildenafil—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00673	CcSEcCtD
Sildenafil—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00671	CcSEcCtD
Sildenafil—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00671	CcSEcCtD
Sildenafil—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00665	CcSEcCtD
Sildenafil—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00665	CcSEcCtD
Sildenafil—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00483	0.00656	CcSEcCtD
Sildenafil—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00652	CcSEcCtD
Sildenafil—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00645	CcSEcCtD
Sildenafil—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00642	CcSEcCtD
Sildenafil—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00616	CcSEcCtD
Sildenafil—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00611	CcSEcCtD
Sildenafil—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00449	0.0061	CcSEcCtD
Sildenafil—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00605	CcSEcCtD
Sildenafil—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00592	CcSEcCtD
Sildenafil—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00428	0.00581	CcSEcCtD
Sildenafil—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00573	CcSEcCtD
Sildenafil—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0057	CcSEcCtD
Sildenafil—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00549	CcSEcCtD
Sildenafil—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.004	0.00543	CcSEcCtD
Sildenafil—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00535	CcSEcCtD
Sildenafil—CYP3A5—nephron tubule—nephrolithiasis	0.00393	0.0207	CbGeAlD
Sildenafil—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00527	CcSEcCtD
Sildenafil—Tension—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00525	CcSEcCtD
Sildenafil—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00519	CcSEcCtD
Sildenafil—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00517	CcSEcCtD
Sildenafil—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00504	CcSEcCtD
Sildenafil—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00501	CcSEcCtD
Sildenafil—CYP2E1—nephron tubule—nephrolithiasis	0.00367	0.0194	CbGeAlD
Sildenafil—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00365	0.00496	CcSEcCtD
Sildenafil—CYP1A1—renal system—nephrolithiasis	0.00365	0.0193	CbGeAlD
Sildenafil—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00494	CcSEcCtD
Sildenafil—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00491	CcSEcCtD
Sildenafil—CYP3A5—renal system—nephrolithiasis	0.00357	0.0189	CbGeAlD
Sildenafil—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00482	CcSEcCtD
Sildenafil—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00354	0.0048	CcSEcCtD
Sildenafil—CYP1A1—kidney—nephrolithiasis	0.00353	0.0186	CbGeAlD
Sildenafil—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00353	0.0048	CcSEcCtD
Sildenafil—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00479	CcSEcCtD
Sildenafil—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00473	CcSEcCtD
Sildenafil—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00346	0.0047	CcSEcCtD
Sildenafil—CYP3A5—kidney—nephrolithiasis	0.00345	0.0182	CbGeAlD
Sildenafil—Cough—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00467	CcSEcCtD
Sildenafil—CYP3A5—cortex of kidney—nephrolithiasis	0.00336	0.0178	CbGeAlD
Sildenafil—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00455	CcSEcCtD
Sildenafil—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00455	CcSEcCtD
Sildenafil—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00455	CcSEcCtD
Sildenafil—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00454	CcSEcCtD
Sildenafil—CYP2E1—renal system—nephrolithiasis	0.00333	0.0176	CbGeAlD
Sildenafil—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00331	0.0045	CcSEcCtD
Sildenafil—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00445	CcSEcCtD
Sildenafil—CYP2E1—kidney—nephrolithiasis	0.00322	0.017	CbGeAlD
Sildenafil—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00436	CcSEcCtD
Sildenafil—Shock—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00429	CcSEcCtD
Sildenafil—CYP2E1—cortex of kidney—nephrolithiasis	0.00314	0.0166	CbGeAlD
Sildenafil—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00426	CcSEcCtD
Sildenafil—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00422	CcSEcCtD
Sildenafil—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00416	CcSEcCtD
Sildenafil—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.003	0.00408	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00398	CcSEcCtD
Sildenafil—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00291	0.00395	CcSEcCtD
Sildenafil—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00392	CcSEcCtD
Sildenafil—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00389	CcSEcCtD
Sildenafil—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00388	CcSEcCtD
Sildenafil—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00384	CcSEcCtD
Sildenafil—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00379	CcSEcCtD
Sildenafil—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00376	CcSEcCtD
Sildenafil—Pain—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00373	CcSEcCtD
Sildenafil—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00373	CcSEcCtD
Sildenafil—CYP3A4—renal system—nephrolithiasis	0.00268	0.0142	CbGeAlD
Sildenafil—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00265	0.0036	CcSEcCtD
Sildenafil—CYP2D6—renal system—nephrolithiasis	0.00264	0.0139	CbGeAlD
Sildenafil—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00357	CcSEcCtD
Sildenafil—CYP3A4—kidney—nephrolithiasis	0.00259	0.0137	CbGeAlD
Sildenafil—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00347	CcSEcCtD
Sildenafil—ABCC5—Defective B3GAT3 causes JDSSDHD—SLC26A1—nephrolithiasis	0.00255	0.0345	CbGpPWpGaD
Sildenafil—CYP2D6—kidney—nephrolithiasis	0.00255	0.0135	CbGeAlD
Sildenafil—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00345	CcSEcCtD
Sildenafil—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00345	CcSEcCtD
Sildenafil—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00322	CcSEcCtD
Sildenafil—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00313	CcSEcCtD
Sildenafil—ABCC10—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0023	0.0311	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0023	0.0311	CbGpPWpGaD
Sildenafil—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00309	CcSEcCtD
Sildenafil—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00299	CcSEcCtD
Sildenafil—ABCC5—NRF2 pathway—SLC2A9—nephrolithiasis	0.00217	0.0293	CbGpPWpGaD
Sildenafil—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00213	0.00289	CcSEcCtD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00205	0.0277	CbGpPWpGaD
Sildenafil—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00277	CcSEcCtD
Sildenafil—Rash—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00275	CcSEcCtD
Sildenafil—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00275	CcSEcCtD
Sildenafil—Headache—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00273	CcSEcCtD
Sildenafil—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00259	CcSEcCtD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00188	0.0253	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00188	0.0253	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Other—CHRM3—nephrolithiasis	0.00161	0.0218	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—SLC2A9—nephrolithiasis	0.0015	0.0203	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00142	0.0192	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00142	0.0192	CbGpPWpGaD
Sildenafil—ABCC5—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00137	0.0185	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00132	0.0178	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00132	0.0178	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—SLC7A9—nephrolithiasis	0.00129	0.0174	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—DGKH—nephrolithiasis	0.00129	0.0174	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00121	0.0163	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00121	0.0163	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00118	0.0159	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00118	0.0159	CbGpPWpGaD
Sildenafil—ADORA2A—G alpha (s) signalling events—PTH—nephrolithiasis	0.00115	0.0155	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00108	0.0145	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000985	0.0133	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000985	0.0133	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000961	0.013	CbGpPWpGaD
Sildenafil—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.000958	0.0129	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000942	0.0127	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000838	0.0113	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000838	0.0113	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ADCY10—nephrolithiasis	0.000781	0.0106	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000747	0.0101	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000747	0.0101	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000747	0.0101	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SLC26A1—nephrolithiasis	0.000719	0.00971	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0007	0.00946	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000694	0.00937	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000694	0.00937	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000694	0.00937	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000692	0.00935	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000683	0.00922	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000683	0.00922	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RGS14—nephrolithiasis	0.000664	0.00897	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000654	0.00883	CbGpPWpGaD
Sildenafil—PDE6G—Disease—ATP6V0A4—nephrolithiasis	0.000641	0.00865	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000619	0.00836	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000619	0.00836	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0006	0.0081	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000535	0.00723	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000529	0.00714	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000518	0.00699	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000518	0.00699	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—SLC7A9—nephrolithiasis	0.000495	0.00669	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—DGKH—nephrolithiasis	0.000495	0.00669	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000495	0.00668	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000492	0.00665	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000488	0.00659	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000481	0.0065	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000481	0.0065	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00048	0.00648	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000457	0.00617	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DGKH—nephrolithiasis	0.000449	0.00606	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000449	0.00606	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GRHPR—nephrolithiasis	0.000429	0.00579	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000429	0.00579	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000429	0.00579	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000418	0.00564	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SLC26A1—nephrolithiasis	0.000388	0.00524	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AGXT—nephrolithiasis	0.000382	0.00516	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000357	0.00482	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ATP6V0A4—nephrolithiasis	0.000346	0.00467	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000343	0.00463	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000334	0.0045	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—APRT—nephrolithiasis	0.000325	0.00439	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SLC26A1—nephrolithiasis	0.000325	0.00439	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CHRM3—nephrolithiasis	0.000324	0.00438	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000324	0.00438	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000322	0.00435	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTH—nephrolithiasis	0.000297	0.00401	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000284	0.00383	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000258	0.00349	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000236	0.00319	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000234	0.00317	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AQP1—nephrolithiasis	0.000232	0.00313	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000216	0.00292	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000214	0.0029	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CHRM3—nephrolithiasis	0.00021	0.00283	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000193	0.0026	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000192	0.00259	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000192	0.00259	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000164	0.00221	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000164	0.00221	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000157	0.00211	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000156	0.00211	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SPP1—nephrolithiasis	0.000149	0.00201	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000148	0.00199	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.00014	0.00188	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000139	0.00188	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000139	0.00187	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000132	0.00178	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTH—nephrolithiasis	0.000127	0.00171	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000121	0.00163	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000119	0.0016	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000119	0.0016	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000118	0.0016	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000118	0.0016	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000117	0.00158	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000112	0.00151	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000112	0.00151	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000111	0.0015	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.00011	0.00149	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000108	0.00145	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000106	0.00143	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AGXT—nephrolithiasis	9.9e-05	0.00134	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AGXT—nephrolithiasis	9.82e-05	0.00133	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APRT—nephrolithiasis	9.16e-05	0.00124	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	9.16e-05	0.00124	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AQP1—nephrolithiasis	8.46e-05	0.00114	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AQP1—nephrolithiasis	8.44e-05	0.00114	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APRT—nephrolithiasis	8.42e-05	0.00114	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	8.42e-05	0.00114	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	8.35e-05	0.00113	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APRT—nephrolithiasis	8.35e-05	0.00113	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AQP1—nephrolithiasis	7.97e-05	0.00108	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CHRM3—nephrolithiasis	7.65e-05	0.00103	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CHRM3—nephrolithiasis	7.63e-05	0.00103	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GRHPR—nephrolithiasis	7.26e-05	0.000981	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CHRM3—nephrolithiasis	7.21e-05	0.000974	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AQP1—nephrolithiasis	6.52e-05	0.000881	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AGXT—nephrolithiasis	6.48e-05	0.000874	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SPP1—nephrolithiasis	6.36e-05	0.000859	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AQP1—nephrolithiasis	6e-05	0.00081	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AQP1—nephrolithiasis	5.95e-05	0.000803	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CHRM3—nephrolithiasis	5.9e-05	0.000797	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	5.51e-05	0.000743	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APRT—nephrolithiasis	5.51e-05	0.000743	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CHRM3—nephrolithiasis	5.43e-05	0.000733	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CHRM3—nephrolithiasis	5.38e-05	0.000726	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AQP1—nephrolithiasis	3.92e-05	0.00053	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CHRM3—nephrolithiasis	3.55e-05	0.000479	CbGpPWpGaD
